Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Acute Crit Care > Volume 35(2); 2020 > Article
Case Report Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation
Dong Kyu Oh1orcid, Tae Sun Shim1orcid, Kyung-Wook Jo1orcid, Seung-Il Park2orcid, Dong Kwan Kim2orcid, Sehoon Choi2orcid, Geun Dong Lee2orcid, Sung-Ho Jung2orcid, Pil-Je Kang2orcid, Sang-Bum Hong1orcid
Acute and Critical Care 2020;35(2):117-121.
DOI: https://doi.org/10.4266/acc.2018.00416
Published online: April 8, 2019

1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

2Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Corresponding author Sang-Bum Hong Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3893 Fax: +82-2-3010-6968 E-mail: hongsangbum@gmail.com
• Received: December 29, 2018   • Revised: February 26, 2019   • Accepted: February 26, 2019

Copyright © 2020 The Korean Society of Critical Care Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 10,606 Views
  • 288 Download
  • 21 Web of Science
  • 22 Crossref
  • 22 Scopus
prev next
Full Article

Download PDF Download PDF

  • Right heart decompensation is a fatal complication in patients with respiratory failure, particularly in those transitioned to lung transplantation using veno-venous extracorporeal membrane oxygenation (V-V ECMO). In these patients, veno-arterial (V-A ECMO) or veno-arterial-venous extracorporeal membrane oxygenation (V-AV ECMO) is used to support both cardiac and respiratory function. However, these processes may increase the risk of device-related complications such as bleeding, thromboembolism, and limb ischemia. In the present case, a 64-year-old male patient with idiopathic pulmonary fibrosis developed respiratory failure and commenced treatment with V-V ECMO as a bridge to lung transplantation. Unfortunately, the patient developed right heart decompensation and required both cardiac and respiratory support during treatment with V-V ECMO. Instead of adding arterial cannulation, he was switched to a novel configuration, a right ventricular assist device with an oxygenator (Oxy-RVAD) using ECMO, with drainage cannulation from the femoral vein and return cannulation to the main pulmonary artery. The patient was successfully bridged to lung transplantation without serious complications after 10 days of Oxy-RVAD support. To the best of our knowledge, this is an extreme rare and challenging case of Oxy-RVAD using ECMO in a patient successfully bridged to lung transplantation.
  • Keywords: extracorporeal membrane oxygenation; heart-assist devices; heart failure; lung transplantation; respiratory insufficiency; right heart bypass
Lung transplantation has become standard-of-care for patients with nonmalignant end-stage lung disease [1]. However, increasing wait time and significant mortalities while on the wait list continues to be an issue, as the need for donor lungs far exceeds their availability [2]. In such patients, veno-venous extracorporeal membrane oxygenation (V-V ECMO) which supports respiratory function, may be considered as a bridge to lung transplantation [3].
Unfortunately, right heart decompensation is a known complication of V-V ECMO and causes hemodynamic instability [4]. Because this potentially-fatal problem requires both cardiac and respiratory support, immediate interventions are required. These can include the addition of arterial cannulation and switching to veno-arterial (V-A ECMO) or veno-arterial-venous ECMO (V-AV ECMO) [4]. However, these configurations may increase the risk of device-related complications such as bleeding, thromboembolism, and limb ischemia and may interfere with early rehabilitation [5].
Herein, we report our extraordinary experience with a novel configuration, a right ventricular assist device with an oxygenator (Oxy-RVAD) using ECMO, in a patient with respiratory failure who developed right heart decompensation during treatment with V-V ECMO. The patient was successfully bridged to lung transplantation, without serious complications, after 10 days of Oxy-RVAD support.
A 64-year-old male (height, 168 cm; weight, 57 kg; body surface area, 1.63 m2) was admitted to Asan Medical Center due to acute exacerbation of idiopathic pulmonary fibrosis. He was treated with broad-spectrum antibiotics and high-dose corticosteroids including pulse therapy with methylprednisolone 500 mg/day for 3 consecutive days. However, the patient’s condition rapidly deteriorated and, unfortunately, he was intubated and transferred to the intensive care unit (ICU) 13 days after hospital admission. The bedside transthoracic echocardiography and the blood level of brain natriuretic peptide (BNP) performed at the time of ICU admission revealed no evidence of resting pulmonary hypertension and right heart decompensation (peak tricuspid valve regurgitation velocity, 2.5 m/sec; tricuspid lateral annulus doppler tissue imaging tricuspid annular peak systolic velocity (S’), 15.9 cm/sec; and BNP, 55 pg/mL) (Table 1).
Because the patient was on a wait list for lung transplantation, we decided to support him with V-V ECMO as a bridge to lung transplantation. Initial V-V ECMO was established the day after ICU admission using a CAPIOX EBS Integrated LX circuit (Terumo Cardiovascular Systems Corp., Tokyo, Japan) which includes an oxygenator and centrifugal pump. After administering 3,000 units of heparin intravenously, cannulation was performed at ICU bedside using the Seldinger technique under ultrasound guidance. A 24-Fr cannula (RMI; Edwards Lifesciences, Irvine, CA, USA) was inserted into the right femoral vein to drain blood from the inferior vena cava. A 17-Fr cannula (Bio-Medicus; Medtronic Inc., Minneapolis, MN, USA) was inserted into the right internal jugular vein to return blood to the right atrium. The initial ECMO flow rate was 3.9 L/min with a fraction of inspired oxygen (FiO2) of 100% and a gas sweep of 4.0 L/min. The initial fraction of recirculated blood was 56%, and was measured using ELSA Monitor (Transonic, Ithaca, NY, USA). Because of the high fraction of recirculated blood, we withdrew the drainage cannula by 5 cm and increased the distance between drainage and return cannulae from 4 cm to 9 cm to reduce recirculation (Figure 1).
A percutaneous dilatational tracheostomy was performed on ECMO day 4, but a bleeding complication occurred at the tracheostomy site. Systemic heparinization was stopped for 24 hours and a topical treatment with 1:1,000 epinephrine-soaked gauze was applied. No systemic hemostatic agents were administered. Unfortunately, blood clots appeared within the oxygenator membrane on ECMO day 5. We therefore decided to change the ECMO circuit, including the oxygenator membrane and centrifugal pump. A second V-V ECMO was established on ECMO day 5 using a QUADROX PLS System (Maquet Cardiopulmonary AG, Rastatt, Germany). An ECMO flow rate of 4.0 L/min was achieved with a FiO2 of 100% and a gas sweep of 4.0 L/min. The fraction of recirculated blood was 43% at the time of EMCO circuit change.
The patient was fully awakened and actively rehabilitated up to standing by participation in our rehabilitation program. However, at ECMO day 17, patient’s right heart function began to worsen (Table 1). The echocardiography revealed Dshaped left ventricle with dilated right ventricle and newly developed resting pulmonary hypertension with right ventricular dysfunction (peak tricuspid valve regurgitation velocity, 3.7 m/sec; tricuspid lateral annulus doppler tissue imaging S’, 6.2 cm/sec). The blood level of BNP also increased to 1,131 pg/mL. Inotropes such as epinephrine were immediately applied, but without improvement in right heart decompensation. As the patient’s condition continued to deteriorate despite all medical treatments, we decided to switch his configuration to a Oxy-RVAD using ECMO to enhance gas exchange, improve hemodynamic stability, and facilitate rehabilitation.
At ECMO day 19, the patient was transferred to the operating room and underwent configuration switching to Oxy-RVAD using ECMO, with drainage cannulation from the left femoral vein and return cannulation to the main pulmonary artery (Figure 2). Under general anesthesia, we performed a 5-cm sized left anterior thoracotomy at the second intercostal space. A 22-Fr cannula (DLP, Medtronic Inc.) was inserted and end-to-side anastomosed to the main pulmonary artery (Figure 3). Because the drain cannula at the right femoral vein was already used for 19 days and a catheter-related infection could not be excluded, a new 24-Fr cannula (RMI, Edwards Life-sciences) was inserted into the left femoral vein, and the previous one on the contralateral side was removed. The patient was then transferred to the ICU and monitored closely. At the time of ICU transfer, we achieved an ECMO flow rate of 3.5 L/min, with a FiO2 of 100% and a gas sweep of 4.0 L/min. Immediately after switching the configuration to Oxy-RVAD using ECMO, the partial pressure of oxygen in arterial blood (PaO2) increased from 77.9 mmHg to 514.0 mmHg under similar ECMO and ventilator settings, suggesting improved efficacy of ECMO and a decreased fraction of recirculated blood.
After 4 days from Oxy-RVAD support, a follow-up echocardiography was performed (Table 1). Although the resting pulmonary hypertension and global right ventricular hypokinesia were still present, both were improved (peak tricuspid valve regurgitation velocity, 3.3 m/sec; tricuspid lateral annulus doppler tissue imaging S’: 7.2 cm/sec). The right ventricle size was decreased to 26 mm and the D-shaped left ventricle was disappeared. The blood level of BNP also decreased to 474 pg/mL. The patient was actively rehabilitated with Oxy-RVAD support and successfully bridged to lung transplantation without serious complication at ECMO day 29, after 10 days from Oxy-RVAD support. The patient was weaned from Oxy-RVAD upon lung transplantation and successfully discharged from the ICU at postoperative day 18.
V-V ECMO may be considered in patients with severe respiratory failure, particularly those awaiting lung transplantation [3]. However, right heart decompensation often occurs and causes hemodynamic instability which requires both cardiac and respiratory supports during treatment with V-V ECMO [4]. There are several current medical treatments for right heart decompensation including fluid optimization, inotropes, adjustment of ventilator settings, and inhaled nitric oxide [4]. However, these may not be sufficient for patients with hemodynamic instability and, in such patients, mechanical support with V-A or V-AV ECMO may be required [4,5].
Adding arterial cannulation to V-A or V-AV ECMO, which is usually accessed peripherally via the femoral artery at bedside, contributes to hemodynamic stability by providing cardiopulmonary support [4,5]. However, like a double-edged sword, it may increase the risk of device-related complications such as bleeding, thromboembolisms, and limb ischemia. Moreover, the peripherally-infused retrograde blood flow into the aorta may also cause catastrophic complications including intracardiac thrombosis and upper body ischemia [5]. In addition, peripherally-inserted arterial cannulation within the inguinal area may interfere with early rehabilitation which is important for patients awaiting lung transplantation, in order to maintain their candidacy [6].
On the other hand, RVAD and Oxy-RVAD seem to provide a more physiological solution for right heart decompensation as these procedures maintain anterograde and normal transpulmonary blood flow [7,8]. Furthermore, Noly et al. [8] reported that RVAD is associated with significantly fewer thromboembolic complications than V-A ECMO. In addition, as the ECMO with central or upper body configuration has strength in rehabilitation compared to peripherally inserted V-A ECMO [9], the Oxy-RVAD using ECMO which has return cannula at main pulmonary artery also has the advantage of allowing patients to get out of bed and participate in physical therapy by virtue of the absence of arterial cannula at inguinal area. Although there are reports that RVAD may increase pulmonary arterial pressure, potentially causing pulmonary hemorrhage in patients with severe pulmonary hypertension [10], these reports are mostly limited to patients with idiopathic pulmonary arterial hypertension which has a different pathophysiology and clinical manifestation than pulmonary hypertension in patients with chronic lung disease. Few patients with chronic lung disease are included among those with severe pulmonary hypertension [11]; therefore, we assume that pulmonary hemorrhages related to RVAD would be identified less-frequently in these patients.
In summary, we report on our extraordinary experience with Oxy-RVAD using ECMO in a patient with both severe respiratory failure and right heart decompensation. The patient was actively rehabilitated and successfully bridged to lung transplantation without serious complications after 10 days of Oxy-RVAD support. To the best of our knowledge, this is an extreme rare and challenging case of Oxy-RVAD using ECMO which was successfully bridged to lung transplantation. This technique may therefore be beneficial to other patients with similar conditions. In addition, the issues related to possible complications of Oxy-RVAD, such as increased pulmonary arterial pressure and pulmonary hemorrhage, also need to be addressed in future studies. However, Oxy-RVAD with ECMO support may provide a successful bridge to lung transplantation may be achieved in a patient with severe respiratory failure and right heart decompensation.

CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS

Conceptualization: all. Data curation: all. Formal analysis: DKO, SBH. Methodology: DKO, SBH. Project administration: DKO, SBH. Visualization: DKO, SBH. Writing - original draft: DKO, SBH. Writing - review & editing: all.

Figure 1.
Chest radiographs showing initial position of drainage and return cannulae (A) and those after adjustment due to recirculation (B). Note that the increased distance between drainage and return cannulae after adjustment.
acc-2018-00416f1.jpg
Figure 2.
A chest radiograph showing drainage cannula at right atrium (RA) and return cannula at main pulmonary artery (MPA) in right ventricular assist device with an oxygenator support.
acc-2018-00416f2.jpg
Figure 3.
A clinical photograph showing end-to-side anastomosis of return cannula to main pulmonary artery in right ventricular assist device with an oxygenator support.
acc-2018-00416f3.jpg
Table 1.
Serial changes in clinical parameters
Variable V-V ECMO Oxy-RVAD After Oxy-RVAD Transplant After transplant
ICU day 2 20 24 30 45
Echocardiography
 Peak TR velocity (m/sec) 2.5 3.7 3.3 Not performed 2.8
 Tricuspid lateral annulus DTI S’ (cm/sec) 15.9 6.2 7.2 Not performed 9.9
Laboratoryfinding
 BNP (pg/mL) 55 1,131 474 297 228
 AST/ALT (IU/L) 29/34 41/32 21/22 27/23 24/46
Medication
 Norepinephrine (μg/kg/min) 0.02 0.08 Not administered Not administered Not administered
 Vasopressin (units/min) 0.02 0.04 Not administered Not administered Not administered
 Epinephrine (μg/kg/min) Not administered 0.10 Not administered Not administered Not administered

V-V ECMO: veno-venous extracorporeal membrane oxygenation; Oxy-RVAD: right ventricular assist device with an oxygenator; ICU: intensive care unit; TR: tricuspid valve regurgitation; DTI: doppler tissue imaging; S’: tricuspid lateral annulus doppler tissue imaging tricuspid annular peak systolic velocity; BNP: brain natriuretic peptide; AST: aspartate transaminase; ALT: alanine transaminase.

  • 1. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184:159-71.ArticlePubMed
  • 2. Valapour M, Skeans MA, Heubner BM, Smith JM, Schnitzler MA, Hertz MI, et al. OPTN/SRTR 2012 annual data report: lung. Am J Transplant 2014;14 Suppl 1:139-65.ArticlePubMed
  • 3. Chiumello D, Coppola S, Froio S, Colombo A, Del Sorbo L. Extracorporeal life support as bridge to lung transplantation: a systematic review. Crit Care 2015;19:19. ArticlePubMedPMCPDF
  • 4. Bunge JJ, Caliskan K, Gommers D, Reis Miranda D. Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018;10(Suppl 5):S674-S82.ArticlePubMedPMC
  • 5. Makdisi G, Wang IW. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015;7:E166-76.PubMedPMC
  • 6. Hoffman M, Chaves G, Ribeiro-Samora GA, Britto RR, Parreira VF. Effects of pulmonary rehabilitation in lung transplant candidates: a systematic review. BMJ Open 2017;7(2):e013445.ArticlePubMedPMC
  • 7. Mohite PN, Sabashnikov A, De Robertis F, Popov AF, Simon AR. Oxy-RVAD: rescue in pulmonary complications after LVAD implantation. Perfusion 2015;30:596-9.ArticlePubMed
  • 8. Noly PE, Kirsch M, Quessard A, Leger P, Pavie A, Amour J, et al. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques. Interact Cardiovasc Thorac Surg 2014;19:49-55.ArticlePubMedPDF
  • 9. Biscotti M, Bacchetta M. The “sport model”: extracorporeal membrane oxygenation using the subclavian artery. Ann Thorac Surg 2014;98:1487-9.ArticlePubMed
  • 10. Gregoric ID, Chandra D, Myers TJ, Scheinin SA, Loyalka P, Kar B. Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2008;27:466-8.ArticlePubMed
  • 11. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013;62(25 Suppl):D109-16.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • The Role of Palliative Care in Cardiovascular Disease
      John Arthur McClung, William H. Frishman, Wilbert S. Aronow
      Cardiology in Review.2024;[Epub]     CrossRef
    • Percutaneous Venopulmonary Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation
      Asad Ali Usman, Audrey Elizabeth Spelde, Wasim Lutfi, Jacob T. Gutsche, William J. Vernick, Omar Toubat, Salim E. Olia, Edward Cantu, Andrew Courtright, Maria M. Crespo, Joshua Diamond, Mauer Biscotti, Christian A. Bermudez
      ASAIO Journal.2024; 70(9): 758.     CrossRef
    • Right Ventricular Assist Device With an Oxygenator for the Management of Combined Right Ventricular and Respiratory Failure: A Systematic Review
      Juliette Beaulieu, Christine Vu, Sanjog Kalra, Hamza Ouazani Chahdi, Julie Cousineau, Alexis Matteau, Samer Mansour, E. Marc Jolicoeur, Sabrina Jacques, Bénédicte Nauche, Renata Podbielski, Pasquale Ferraro, Charles Poirier, Brian J. Potter
      Canadian Journal of Cardiology.2024; 40(9): 1732.     CrossRef
    • Percutaneous OxyRVAD in a Patient with Severe Respiratory Failure and Right Heart Failure: A Case Report
      Ga Young Yoo, June Lee, Seok Beom Hong, Do Yeon Kim
      Journal of Chest Surgery.2024; 57(3): 319.     CrossRef
    • Central Venopulmonary Extracorporeal Membrane Oxygenation: Background and Standardized Nomenclature
      J. Michael Brewer, Roberto Lorusso, L. Mikael Broman, Steven A. Conrad, Justyna Swol, Marc O. Maybauer
      ASAIO Journal.2024; 70(9): e123.     CrossRef
    • Outcomes of Lung Transplantation in Patients With Right Ventricular Dysfunction: A Single-Center Retrospective Analysis Comparing ECMO Configurations in a Bridge-to-Transplant Setting
      Su Yeon Lee, Jee Hwan Ahn, Ho Cheol Kim, Tae Sun Shim, Pil-Je Kang, Geun Dong Lee, Se Hoon Choi, Sung-Ho Jung, Seung-Il Park, Sang-Bum Hong
      Transplant International.2024;[Epub]     CrossRef
    • Venopulmonary extracorporeal membrane oxygenation for right ventricular support as a bridge to lung transplantation: A narrative review
      Phan Quang Thuan, Nguyen Hoai Nam, Nguyen Hoang Dinh
      SAGE Open Medicine.2024;[Epub]     CrossRef
    • Early Mobilization for a Patient With a Right Ventricular Assist Device With an Oxygenator
      Sheena MacFarlane, Vanessa Lee, Adrienne H. Simonds, Samantha Alvarez, Samantha Carty, Kevin H. Ewers, Victoria R. Kelly, Parker Linden, Amanda L. Moskal
      Journal of Acute Care Physical Therapy.2023; 14(1): 45.     CrossRef
    • A 35-month-old boy who ingested laundry detergent pods and underwent veno-pulmonary extracorporeal membrane oxygenation support
      Hye-ji Han, Bongjin Lee, Won Jin Jang, Ji Won Lee, Jin Hee Kim, Sungkyu Cho, June Dong Park
      Pediatric Emergency Medicine Journal.2023; 10(4): 175.     CrossRef
    • Right Ventricular Assist Device With Extracorporeal Membrane Oxygenation for Bridging Right Ventricular Heart Failure to Lung Transplantation: A Single-Center Case Series and Literature Review
      Jae Guk Lee, Chuiyong Pak, Dong Kyu Oh, Ho Cheol Kim, Pil-Je Kang, Geun Dong Lee, Se Hoon Choi, Sung-Ho Jung, Sang-Bum Hong
      Journal of Cardiothoracic and Vascular Anesthesia.2022; 36(6): 1686.     CrossRef
    • Advanced Circulatory Support and Lung Transplantation in Pulmonary Hypertension
      Marie M. Budev, James J. Yun
      Cardiology Clinics.2022; 40(1): 129.     CrossRef
    • A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients
      Heather Torbic, Benjamin Hohlfelder, Sudhir Krishnan, Adriano R. Tonelli
      Journal of Cardiovascular Pharmacology and Therapeutics.2022;[Epub]     CrossRef
    • A Comprehensive Review of Mechanical Circulatory Support Devices
      Varunsiri Atti, Mahesh Anantha Narayanan, Brijesh Patel, Sudarshan Balla, Aleem Siddique, Scott Lundgren, Poonam Velagapudi
      Heart International.2022; 16(1): 37.     CrossRef
    • Comprehensive Monitoring in Patients With Dual Lumen Right Atrium to Pulmonary Artery Right Ventricular Assist Device
      Asad A. Usman, Audrey E. Spelde, Michael Ibrahim, Marisa Cevasco, Christian Bermudez, Emily MacKay, Sameer Khandhar, Wilson Szeto, William Vernick, Jacob Gutsche
      ASAIO Journal.2022; 68(12): 1461.     CrossRef
    • Percutaneous Pulmonary Artery Cannulation to Treat Acute Secondary Right Heart Failure While on Veno-venous Extracorporeal Membrane Oxygenation
      Kelly M. Ivins-O’Keefe, Michael S. Cahill, Arthur R. Mielke, Michal J. Sobieszczyk, Valerie G. Sams, Phillip E. Mason, Matthew D. Read
      ASAIO Journal.2022; 68(12): 1483.     CrossRef
    • The ProtekDuo for percutaneous V-P and V-VP ECMO in patients with COVID-19 ARDS
      Ahmed M El Banayosy, Aly El Banayosy, Joseph M Brewer, Mircea R Mihu, Jaclyn M Chidester, Laura V Swant, Robert S Schoaps, Ammar Sharif, Marc O Maybauer
      The International Journal of Artificial Organs.2022; 45(12): 1006.     CrossRef
    • Critical Care Management of the Patient with Pulmonary Hypertension
      Christopher J. Mullin, Corey E. Ventetuolo
      Clinics in Chest Medicine.2021; 42(1): 155.     CrossRef
    • Successful Lung Transplantation After 213 Days of Extracorporeal Life Support: Role of Oxygenator-Right Ventricular Assist Device
      Jae Kyeom Sim, Kyeongman Jeon, Gee Young Suh, Suryeun Chung, Yang Hyun Cho
      ASAIO Journal.2021; 67(7): e127.     CrossRef
    • Oxy-right Ventricular Assist Device for Bridging of Right Heart Failure to Lung Transplantation
      Sung Kwang Lee, Do Hyung Kim, Woo Hyun Cho, Hye Ju Yeo
      Transplantation.2021; 105(7): 1610.     CrossRef
    • Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
      Tomasz Stącel, Magdalena Latos, Maciej Urlik, Mirosław Nęcki, Remigiusz Antończyk, Tomasz Hrapkowicz, Marcin Kurzyna, Marek Ochman
      Journal of Clinical Medicine.2021; 10(15): 3326.     CrossRef
    • Intraoperative Management of Adult Patients on Extracorporeal Membrane Oxygenation: an Expert Consensus Statement From the Society of Cardiovascular Anesthesiologists—Part I, Technical Aspects of Extracorporeal Membrane Oxygenation
      Michael A. Mazzeffi, Vidya K. Rao, Jeffrey Dodd-o, Jose Mauricio Del Rio, Antonio Hernandez, Mabel Chung, Amit Bardia, Rebecca M. Bauer, Joseph S. Meltzer, Sree Satyapriya, Raymond Rector, James G. Ramsay, Jacob Gutsche
      Journal of Cardiothoracic and Vascular Anesthesia.2021; 35(12): 3496.     CrossRef
    • Intraoperative Management of Adult Patients on Extracorporeal Membrane Oxygenation: An Expert Consensus Statement From the Society of Cardiovascular Anesthesiologists—Part I, Technical Aspects of Extracorporeal Membrane Oxygenation
      Michael A. Mazzeffi, Vidya K. Rao, Jeffrey Dodd-o, Jose Mauricio Del Rio, Antonio Hernandez, Mabel Chung, Amit Bardia, Rebecca M. Bauer, Joseph S. Meltzer, Sree Satyapriya, Raymond Rector, James G. Ramsay, Jacob Gutsche
      Anesthesia & Analgesia.2021;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation
      Acute Crit Care. 2020;35(2):117-121.   Published online April 8, 2019
      DOI: https://doi.org/10.4266/acc.2018.00416
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    Related articles
    Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation
    Image Image Image
    Figure 1. Chest radiographs showing initial position of drainage and return cannulae (A) and those after adjustment due to recirculation (B). Note that the increased distance between drainage and return cannulae after adjustment.
    Figure 2. A chest radiograph showing drainage cannula at right atrium (RA) and return cannula at main pulmonary artery (MPA) in right ventricular assist device with an oxygenator support.
    Figure 3. A clinical photograph showing end-to-side anastomosis of return cannula to main pulmonary artery in right ventricular assist device with an oxygenator support.

    Figure 1.

    Figure 2.

    Figure 3.

    Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation
    Variable V-V ECMO Oxy-RVAD After Oxy-RVAD Transplant After transplant
    ICU day 2 20 24 30 45
    Echocardiography
     Peak TR velocity (m/sec) 2.5 3.7 3.3 Not performed 2.8
     Tricuspid lateral annulus DTI S’ (cm/sec) 15.9 6.2 7.2 Not performed 9.9
    Laboratoryfinding
     BNP (pg/mL) 55 1,131 474 297 228
     AST/ALT (IU/L) 29/34 41/32 21/22 27/23 24/46
    Medication
     Norepinephrine (μg/kg/min) 0.02 0.08 Not administered Not administered Not administered
     Vasopressin (units/min) 0.02 0.04 Not administered Not administered Not administered
     Epinephrine (μg/kg/min) Not administered 0.10 Not administered Not administered Not administered
    Table 1. Serial changes in clinical parameters

    V-V ECMO: veno-venous extracorporeal membrane oxygenation; Oxy-RVAD: right ventricular assist device with an oxygenator; ICU: intensive care unit; TR: tricuspid valve regurgitation; DTI: doppler tissue imaging; S’: tricuspid lateral annulus doppler tissue imaging tricuspid annular peak systolic velocity; BNP: brain natriuretic peptide; AST: aspartate transaminase; ALT: alanine transaminase.

    Table 1.

    ACC : Acute and Critical Care
    © The Korean Society of Critical Care Medicine.
    TOP